"L’hôpital Ambroise-Paré est un hôpital de l’AP-HP situé à Boulogne-Billancourt, dans les Hauts-de-Seine (92). Centré sur la phase aiguë et ambulatoire des soins, il propose une large gamme de spécialités pour l’adulte et l’enfant. Alliant activités d’excellence et soins de proximité, notamment avec ses urgences adultes et pédiatriques, l’hôpital assure une prise en charge en chirurgie orthopédique, en cancérologie (dermatologie, cancers digestifs, pneumologie, oncogériatrie) en complémentarité avec l’Institut Curie – René Huguenin, mais également sur un large panel de disciplines médicales spécialisées. Il accueille également trois centres de référence spécialisés en nutrition clinique, infections ostéo-articulaires et maladies rares."

During the past decade, Service de médecine interne, Hôpital Ambroise Paré, APHP conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Service de médecine interne, Hôpital Ambroise Paré, APHP" are "Infective Endocarditis" (2 trials). Many other conditions were trialed in "Service de médecine interne, Hôpital Ambroise Paré, APHP" in a lesser frequency.

Most popular intervention types in "Service de médecine interne, Hôpital Ambroise Paré, APHP" are "Drug" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Amoxicillin" (1 trials), "Conventional IV treatment of staphylococci IE following European guidelines 2015 including cloxacilline, oxacilline,gentamicine,vancomycine,rifampicine" (1 trials), "Conventional IV treatment of streptococci/enterococci IE following European guidelines 2015 including amoxicillin, gentamicin, amicillin, vancomycin, penicillin G, ceftriaxone, netilmicin" (1 trials), "Levofloxacin" (1 trials) and "Rifampicin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Service de médecine interne, Hôpital Ambroise Paré, APHP" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Service de médecine interne, Hôpital Ambroise Paré, APHP". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Service de médecine interne, Hôpital Ambroise Paré, APHP, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Service de médecine interne, Hôpital Ambroise Paré, APHP, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".